top of page
NJ.jpg

IN THE STATES

NEW JERSEY

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in New Jersey in 2022.

NJ.png

Download vendor data for New Jersey:

Economic
Output

$120.9B

Direct Jobs Supported by the Industry

75,833

Total Jobs Supported

356,725

State Total Vendor Relationships

4,281

State Total Vendor Spending

$6,601,301,465

Clinical
Trials

792

Investments at Clinical Trial Sites

$320.4M

Clinical Trial Participants

16,649

Total Economic Impact of Clinical Trial Sites

$879.7M

bottom of page